NFOCUS NEUROMEDICAL
Nfocus Neuromedical, Inc. designs, develops, and markets endovascular neurosurgery solutions to cure intracranial aneurysms. The company offers revolutionary systems to treat neurovascular disease, including brain aneurysms. The company was formerly known as CardioVasc, Inc. and changed its name to Nfocus Neuromedical, Inc. in April 2007. The company was incorporated in 1997 and is based in Palo Alto, California. As of February 19, 2013, Nfocus Neuromedical, Inc. operates as a subsidiary of Covidien plc.
NFOCUS NEUROMEDICAL
Industry:
Hardware Health Care Software
Founded:
1997-01-01
Address:
Palo Alto, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
20.3 M USD
Similar Organizations
Nexalin Technology
Nexalin Technology develops transcranial electrical stimulation equipment for the treatment of anxiety, insomnia, and depression.
WellApps
WellApps develops and distributes symptom tracking applications for patients with chronic illnesses.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2008-03-08 | StarFire Medical | StarFire Medical acquired by Nfocus Neuromedical | N/A |
| 2007-04-03 | Acta Vascular Systems | Acta Vascular Systems acquired by Nfocus Neuromedical | N/A |
Investors List
Endeavour Vision
Endeavour Vision investment in Series C - Nfocus Neuromedical
Technology Partners
Technology Partners investment in Series B - Nfocus Neuromedical
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series B - Nfocus Neuromedical